Aneurysmal subarachnoid hemorrhage (SAH) causes devastating rates of mortality and morbidity. Accumulating studies indicate that early brain injury (EBI) greatly contributes to poor outcomes after SAH and that oxidative stress plays an important role in the development of EBI following SAH. Astaxanthin (ATX), one of the most common carotenoids, has a powerful antioxidative property. However, the potential role of ATX in protecting against EBI after SAH remains obscure. The goal of this study was to assess whether ATX can attenuate SAH-induced brain edema, blood-brain barrier permeability, neural cell death, and neurological deficits, and to elucidate whether the mechanisms of ATX against EBI are related to its powerful antioxidant property.
Two experimental SAH models were established, including a prechiasmatic cistern SAH model in rats and a one-hemorrhage SAH model in rabbits. Both intracerebroventricular injection and oral administration of ATX were evaluated in this experiment. Posttreatment assessments included neurological scores, body weight loss, brain edema, Evans blue extravasation, Western blot analysis, histopathological study, and biochemical estimation.
It was observed that an ATX intracerebroventricular injection 30 minutes post-SAH could significantly attenuate EBI (including brain edema, blood-brain barrier disruption, neural cell apoptosis, and neurological dysfunction) after SAH in rats. Meanwhile, delayed treatment with ATX 3 hours post-SAH by oral administration was also neuroprotective in both rats and rabbits. In addition, the authors found that ATX treatment could prevent oxidative damage and upregulate the endogenous antioxidant levels in the rat cerebral cortex following SAH.
These results suggest that ATX administration could alleviate EBI after SAH, potentially through its powerful antioxidant property. The authors conclude that ATX might be a promising therapeutic agent for EBI following SAH.
BedersonJB, GermanoIM, GuarinoL: Cortical blood flow and cerebral perfusion pressure in a new noncraniotomy model of subarachnoid hemorrhage in the rat. Stroke26:1086–1092, 199510.1161/01.STR.26.6.1086)| false
DurisK, ManaenkoA, SuzukiH, RollandWB, KrafftPR, ZhangJH: α7 nicotinic acetylcholine receptor agonist PNU-282987 attenuates early brain injury in a perforation model of subarachnoid hemorrhage in rats. Stroke42:3530–3536, 201110.1161/STROKEAHA.111.619965)| false
FangQ, , ChenG, , ZhuW, , DongW, & WangZ: Influence of melatonin on cerebrovascular proinflammatory mediators expression and oxidative stress following subarachnoid hemorrhage in rabbits. Mediators Inflamm2009:426346, 2009
FangQ, ChenG, ZhuW, DongW, WangZ: Influence of melatonin on cerebrovascular proinflammatory mediators expression and oxidative stress following subarachnoid hemorrhage in rabbits. Mediators Inflamm2009:426346, 2009)| false
PlutaRM, , Hansen-SchwartzJ, , DreierJ, , VajkoczyP, , MacdonaldRL, & NishizawaS, et al.: Cerebral vasospasm following subarachnoid hemorrhage: time for a new world of thought. Neurol Res31:151–158, 2009
PlutaRM, Hansen-SchwartzJ, DreierJ, VajkoczyP, MacdonaldRL, NishizawaS, : Cerebral vasospasm following subarachnoid hemorrhage: time for a new world of thought. Neurol Res31:151–158, 200910.1179/174313209X393564)| false
YouWC, , LiW, , ZhuangZ, , TangY, , LuHC, & JiXJ, et al.: Biphasic activation of nuclear factor-kappa B in experimental models of subarachnoid hemorrhage in vivo and in vitro. Mediators Inflamm2012:786242, 2012
YouWC, LiW, ZhuangZ, TangY, LuHC, JiXJ, : Biphasic activation of nuclear factor-kappa B in experimental models of subarachnoid hemorrhage in vivo and in vitro. Mediators Inflamm2012:786242, 2012)| false